Evidence map›Paper›PMID 2649022›Full record

Trial reportAnnals of the rheumatic diseases1989

Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids.

J Jäntti, T Nikkari, T Solakivi, H Vapaatalo, H Isomäki

Open access · bronzeAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in Annals of the rheumatic diseases, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Herbal therapy for treating rheumatoid arthritis.The Cochrane database of systematic reviews · 2011
    Pooled it
  4. Effects of evening primrose oil in rheumatoid arthritis.Annals of the rheumatic diseases · 1989
    Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Essential fatty acids and inflammation.Annals of the rheumatic diseases · 1991
    Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

J JänttiRheumatism Foundation Hospital, Heinola, Finland.
T Nikkari
T Solakivi
H Vapaatalo
H Isomäki

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The serum concentration of lipids and composition of fatty acids after overnight fasting were studied in 18 patients with rheumatoid arthritis treated for 12 weeks with either 20 ml of evening primrose oil containing 9% of gamma-linolenic acid or olive oil. The serum concentrations of oleic acid, eicosapentaenoic acid, and apolipoprotein B decreased and those of linoleic acid, gamma-linolenic acid, dihomo-gamma-linolenic acid, and arachidonic acid increased during treatment with evening primrose oil. During olive oil treatment the serum concentration of eicosapentaenoic acid decreased and those of high density lipoprotein-cholesterol and apolipoprotein A-I increased slightly. The decrease in serum eicosapentaenoic acid and the increase in arachidonic acid concentrations induced by evening primrose oil may not be favourable effects in patients with rheumatoid arthritis in the light of the roles of these fatty acids as precursors of eicosanoids.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalArthritis, RheumatoidClinical Trials as TopicDietary Fats, UnsaturatedDouble-Blind MethodFatty AcidsFatty Acids, Essentialgamma-Linolenic AcidHumansLinoleic AcidsLipidsMiddle AgedOenothera biennisOlive OilPlant OilsRandom AllocationAnti-Inflammatory Agents, Non-SteroidalDietary Fats, Unsaturatedevening primrose oilFatty AcidsFatty Acids, Essentialgamma-Linolenic AcidLinoleic AcidsLipidsOlive OilPlant Oils

Identifiers

PMID2649022
PMCPMC1003697
OpenAlexW2087840280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.